HomeMWG • FRA
add
InMed Pharmaceuticals Inc
Previous close
€4.34
Day range
€4.11 - €4.28
Year range
€3.89 - €5.68
Market cap
3.11M USD
Avg Volume
59.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 1.26M | 40.23% |
Operating expense | 2.25M | -15.04% |
Net income | -1.68M | 33.86% |
Net profit margin | -132.68 | 52.83% |
Earnings per share | — | — |
EBITDA | -1.70M | 33.85% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.63M | -17.03% |
Total assets | 10.47M | -4.14% |
Total liabilities | 2.07M | 54.54% |
Total equity | 8.40M | — |
Shares outstanding | 718.03K | — |
Price to book | 0.34 | — |
Return on assets | -39.35% | — |
Return on capital | -44.70% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -1.68M | 33.86% |
Cash from operations | -1.83M | 15.98% |
Cash from investing | 0.00 | — |
Cash from financing | 838.24K | — |
Net change in cash | -988.57K | 54.53% |
Free cash flow | -1.14M | 3.37% |
About
Founded
1981
Headquarters
Website
Employees
13
